Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP3 | P05413 | 1/20 | 0.49 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 4/20 | 0.35 |
| ▸ | NCEH1 | Q6PIU2 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.33 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.33 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.33 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5460219 | 0.90 | FABP3 (0.49) | FABP3MRGPRX4CYP3A4MAPK1TSHR | |
| SCHEMBL121772 | 0.86 | FABP3 (0.49) | FABP3MRGPRX4CYP3A4MAPK1TSHR | |
| SCHEMBL30552290 | 0.86 | FABP3 (0.49) | FABP3MRGPRX4CYP3A4MAPK1TSHR | |
| SCHEMBL9662600 | 0.86 | FABP3 (0.43) | FABP3MRGPRX4CYP3A4MAPK1TSHR | |
| SCHEMBL1153425 | 0.86 | FABP3 (0.43) | FABP3MRGPRX4CYP3A4MAPK1TSHR | |
| SCHEMBL31105888 | 0.84 | FABP3 (0.51) | FABP3MRGPRX4CYP3A4MAPK1TSHR | |
| SCHEMBL2849811 | 0.84 | FABP3 (0.47) | FABP3MRGPRX4CYP3A4MAPK1TSHR | |
| SCHEMBL121773 | 0.84 | FABP3 (0.51) | FABP3MRGPRX4CYP3A4MAPK1TSHR | |
| SCHEMBL28200215 | 0.83 | FABP3 (0.41) | FABP3MRGPRX4CYP3A4MAPK1TSHR | |
| SCHEMBL8860109 | 0.83 | KDM4E (0.50) | FABP3MRGPRX4CYP3A4MAPK1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0432017-B1 | Derivatives of tetrahydro-2,3,6,7,1H,5H,11H-(1)benzopyrano(6,7,8,ij)quinolizinone-11 usable as markers for organic compounds for the purpose of detecting said compounds by chemiluminescence or fluorescence | EUROBIO LAB (FR) | 1995-08-16 | — | — | EP | claimed |
| EP-0419542-B1 | NEW DERIVATIVES OF TETRAHYDRO-2,3,6,7,1H,5H,11H-(1)BENZOPYRANO(6,7,8,IJ)QUINOLIZONONE-11 USABLE AS MARKERS FOR ORGANIC COMPOUNDS FOR THE PURPOSE OF DETECTING SAID COMPOUNDS BY CHEMILUMINESCENCE OR FLUORESCENCE | LABORATOIRES EUROBIO (FR) | 1993-09-29 | — | — | EP | claimed |
| US-20250064339-A1 | SENSOR DEVICES AND SYSTEMS FOR MONITORING MARKERS IN BREATH | BIOLUM SCIENCES LLC (US) | 2025-02-27 | — | — | US | disclosed |
| US-11903695-B2 | Sensor devices and systems for monitoring markers in breath | BIOLUM SCIENCES LLC (US) | 2024-02-20 | — | — | US | disclosed |
| US-20210041467-A1 | METHODS FOR ASSESSING THE NEED FOR AND THE EFFECTIVENESS OF THERAPY WITH ANTIOXIDANTS | THE PROIMMUNE COMPANY, LLC | 2021-02-11 | — | — | US | disclosed |
| US-20200141956-A1 | METHODS OF ASSESSING THE NEED FOR AND THE EFFECTIVENESS OF THERAPY WITH ANTIOXIDANTS | THE PROIMMUNE COMPANY, LLC | 2020-05-07 | — | — | US | disclosed |
| US-20160341748-A1 | Methods of assessing the need for and the effectiveness of therapy with antioxidants | CRUM ALBERT B (US) | 2016-11-24 | — | — | US | disclosed |
| US-9229014-B2 | Methods of assessing the need for and the effectiveness of therapy with antioxidants | THE PROIMMUNE COMPANY, LLC | 2016-01-05 | — | — | US | disclosed |
| EP-1934598-B1 | DIAGNOSIS OF OBLIGATE INTRACELLULAR PATHOGENS | PETYAEV IVAN MIKHAILOVICH (GB) | 2010-09-22 | — | — | EP | disclosed |
| EP-1456670-B1 | METHODS RELATING TO TREATMENT OF ATHEROSCLEROSIS | CAMBRIDGE THERANOSTICS LTD (GB) | 2009-07-15 | — | — | EP | disclosed |
| EP-1454140-B1 | DIAGNOSIS AND TREATMENT OF ATHEROSCLEROSIS | CAMBRIDGE THERANOSTICS LTD (GB) | 2009-07-08 | — | — | EP | disclosed |
| US-4621059-A | Apparatus for measuring velocity of enzyme reaction | KABUSHIKI KAISHA TOSHIBA (JP) | 1986-11-04 | — | — | US | disclosed |
| EP-0173375-A1 | Novel assay product and process | POLAROID CORPORATION (US) | 1986-03-05 | — | — | EP | disclosed |
| EP-0156204-A2 | Apparatus for measuring velocity of enzyme reaction | KABUSHIKI KAISHA TOSHIBA (JP) | 1985-10-02 | — | — | EP | disclosed |
| EP-0140521-A2 | Specific binding assay | Bayer Corporation (US) | 1985-05-08 | — | — | EP | disclosed |
| EP-0032131-B1 | 5-HALO-PYRIMIDIN-2-ONES, THE SALTS THEREOF, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | NYEGAARD & CO. A/S (NO) | 1983-09-21 | — | — | EP | disclosed |
| US-4396579-A | IMMUNOASSAY | MILES LABORATORIES, INC. (US) | 1983-08-02 | — | — | US | disclosed |
| EP-0071859-A2 | Luminescence detection device | MILES LABORATORIES, INC. (US) | 1983-02-16 | — | — | EP | disclosed |
| US-4365018-A | SELF-EXPOSING, CHEMILUMINESCENCE | THE MEAD CORPORATION (US) | 1982-12-21 | — | — | US | disclosed |
| US-4313843-A | CHEMILUMINESCENT HAVING GOOD STORAGE STABILITY | AMERICAN CYANAMID COMPANY (US) | 1982-02-02 | — | — | US | disclosed |